Oral Presentations

All oral presentations will be made in the Grand Ballroom of the Hyatt Centric Magnificent Mile (2^nd floor). Speakers, please prepare your slides in the widescreen format, which has a 16:9 aspect ratio. This is the default slide size in the newer versions of Powerpoint.

Poster Presentations

Each poster board is 4 feet high and 8 feet wide. Odd numbered posters will be presented on Monday, and even numbered posters will be presented on Tuesday. The poster sessions will be held from 5:10-7:00 PM on the 3rd floor of the Hyatt Centric Magnificent Mile. All posters should be put up on Monday by lunch, and will be displayed until Wednesday at lunch.

List of Posters

1 - Political Priority for Tobacco Control among Adolescents in Local Governments Areas, Osun State, Nigeria
Ademola Adelekan

2 - Effectiveness of Provider Initiative Approach for Smoking Cessation among Pregnant Women in Osun State, Nigeria
Ademola Adelekan

3 - Ring Substitution in the Macrocyclic Opioid Peptide CJ-15,208 Alters the Opioid Activity Profile in vivo
J. V. Aldrich

4 - Identification of a novel interaction site of the mu-delta opioid receptor heterodimers
Doungkamol Alongkronrusmee

5 - Low Abuse Liability of the Endomorphin Analog ZH853 is Supported by Reduced Psychomotor Activation and Withdrawal.
Ariel Amgott-Kwan

6 - Morphine influences cell proliferation, migration and apoptosis of tumor cell lines endogenously expressing mu opioid receptors
Andrea Bedini

7 - OREX-1019; a small molecule with potential for addiction maintenance treatment and relapse prevention
Barbara Belli PhD

8 - OREX-1038; a potent analgesic molecule with potential for reduced abuse liability
Barbara Belli PhD

9 - Rewarding effects of opioidergic projections from the ventral pallidum to substantia nigra
Julio Bernardi

10 - Opioid receptors modulate skin ageing and melanocytic disorders
Bigliardi PL1

11 - μ-Opioid receptor trafficking in human keratinocytes
Bigliardi-Qi M*

12 - Opioid modulation of synaptic transmission in affective pain circuitry
William Birdsong

13 - Antidepressant activity of the buprenorphine analog BU10119
Caroline A. Browne

14 - Peripherally restricted opioid combination therapy synergizes in multiple pain states
Daniel J. Bruce

15 - Characterization of opioid receptor subtypes and biased signalling as factors for modulation of alcohol use in mice.
Robert J. Cassell

16 - Nucleus accumbens mu-opioid receptors are recruited and necessary for the enhancement of motivated behaviors
Daniel C Castro

17 - Characterization of Sigma 1 Receptor (S1R) antagonist CM-304 and a related analog, AZ-66: Evaluating novel therapeutics for allodynia and induced pain
Thomas J. Cirino

18 - Oxycodone-induced conditioned place preference and locomotor activity in male and female Oprm1 A112G mice
Devon Collins

19 - A neural network for abstracting nociceptive information into an aversive pain perception
Gregory Corder

20 - On Target effects of Mu opioid receptor activation on brain activity and connectivity identified by mouse fMRI
Emmanuel Darcq

21 - Differential regulation of delta opioid receptor-mediated behaviors by arrestin2 in mice
Isaac J. Dripps

22 - Distinct MOR agonist profiles revealed by visualizing Mu opioid receptor trafficking with MOR-Venus mice
Aliza T. Ehrlich

23 - Percutaneous Electrical Nerve Stimulation (Electro-Acupuncture) elevates Agmatine in Spinal Cords of Nerve-Injured Rats.
Samuel J. Erb

24 - Evaluation of opioid-nociceptin bifunctional ligands by biochemical, pharmacological and structural modeling tools
Anna I. Erdei

25 - How did the Opioid System Evolve?
Chris Evans

26 - The role of striatal mu opioid receptor populations in reward-related behaviors.
Christopher Evans

27 - The role of the deorphanized receptor, GPR83, in stress and reward.
Amanda K. Fakira

28 - Assessment of ZH853, a novel endomorphin analog, versus morphine in acute and long term dosing for chronic pain.
Amy Feehan

29 - Structural Insights into Opioid Peptidomimetics with Bifunctional Mu-Opioid Agonism and Delta-Opioid Antagonism
Thomas Fernández

30 - Structural and Dynamic Elements of µ-Opioid Receptor Functional Selectivity
Marta Filizola

31 - Characterizing the biochemical and synaptic properties of CNIH3, a novel component in individual risk for opioid dependence
Hannah Frye

32 - Mechanistic insights into opioid-induced chemoresistance in breast cancer cells: DOR stimulation increases P-glycoprotein abundance by exploiting EphA2/c-src signaling
Daniela A. Fux

33 - Investigating delta opioid receptors in a new conditional knockin mouse
Louis Gendron

34 - Oxycodone conditioned place preference alters hippocampal mossy fiber leu-enkephalin levels in a sex-dependent manner
Jason D. Gray

35 - Delta-opioid receptor (DOR) antagonism/inverse agonism reduces the development of mu-opioid receptor (MOR) tolerance
Nicholas Griggs

36 - Selective Inhibition of M5 Muscarinic Acetylcholine Receptors Attenuates Remifentanil Self-Administration without Blocking Morphine-induced Analgesia in Rats
Barak W. Gunter

37 - Functional consequences of OPRM1 A118G (MOR N40D) on human neurotransmission
Apoorva Halikere

38 - Crucial role of the κ-opioid receptor system in tumor angiogenesis
Yusuke Hamada

39 - CaMKIIα controls the biogenesis of let-7 microRNAs in opioid tolerance
Ying He

40 - The G-protein Biased Opioid Agonist PZM21 Does Indeed Depress Respiration
Rob Hill

41 - INFLAMMATORY PAIN ALTERS THE VULNERABILITIY TO ALCOHOL RELAPSE WITHOUT IMPACTING THE INTENSITY OF THE RELAPSE IN RATS.
Lucia Hipolito

42 - Simultaneous administration of a chemokine receptor antagonist with morphine enhances the analgesic effect of morphine on incisional pain in rats
S. Inan

43 - Dermatolgical manifestations in substance abuse and how the community responses in developing country
Shambhu D Joshi

44 - Opioid receptors reveal a parallel cycle of regulated presynaptic membrane trafficking
Damien Jullie

45 - Probe Dependence of High and Low Affinity Agonist Binding to the Delta Opioid Receptor is Allosterically Regulated by BMS-986187 and Na+ Ions
Evan Schramm

46 - Allosteric Agonism at the Delta Opioid Receptor: Potential Mechanism for Functional Selectivity
Matthew Stanczyk

47 - Allosteric activation of delta opioid receptors in vivo: promising behavioral profile
Emily Jutkiewicz

48 - Analysis of medication overuse headache after repeated morphine or THC administration using home cage wheel running
Ram Kandasamy

49 - Effect of opioids on the cellular responses to anti-cancer drugs
Leena Karhinen

50 - Adolescent social isolation increases kappa opioid receptor function in the nucleus accumbens and basolateral amygdala of rats.
Anushree N. Karkhanis

51 - Norbuprenorphine pharmacokinetics and pharmacodynamics: First in man evaluation
Evan D. Kharasch

52 - Serum and urine concentrations of morphine and morphine metabolites in patients with advanced cancer receiving continuous intravenous morphine: an observational study
Soo Jin Kim

53 - Evaluation of the dual kappa and delta opioid receptor agonist MP1104 in rat models of cocaine self-administration, analgesia and behavioural side-effects
Bronwyn Kivell

54 - Regulation of morphine sensitivity and adenylate cyclase sensitization by carboxyl-terminus of V1b vasopressin receptors
Taka-aki Koshimizu

55 - Generation and characterization analysis of human iPS cell derived-sensory neurons as a useful research tool for pain and opioid systems
Naoko Kuzumaki

56 - Factors associated with ketamine use in pancreatic cancer patient in a single hospice center
Kyung min Kwon

57 - Sex differences in opioid signaling
Emily Leff

58 - Genetic deletion of mu opioid receptors from Kölliker-Fuse neurons reduces morphine-induced respiratory depression
Erica Levitt

59 - Cannabinoid CB2 receptor plasticity in rostral ventromedial medulla in inflammatory pain
Ming-Hua Li*

60 - The CB2 cannabinoid receptor agonist LY2828360 suppresses chemotherapy-induced neuropathic pain with sustained efficacy and attenuates morphine tolerance and dependence
Xiaoyan Lin

61 - Kappa opioid receptor up-regulation contributes to mood and reward dysregulation in neuropathic pain
Shiwei Liu

62 - The role of endogenous dynorphins in amphetamine sensitization and depression-like behaviors in mice
Kabirullah Lutfy

63 - AT-328, a selective NOP agonist, reduces the rewarding action of ethanol and cocaine
Kabirullah Lutfy

64 - The role of mu opioid receptors in hyperlocomotion and sensitization induced by amphetamine
Kabirullah Lutfy

65 - Male but not female mice lacking nociceptin exhibit higher anxiety and enhanced reward following exposure to the elevated plus maze test
Kabirullah Lutfy

66 - Activation of δOR alleviates κOR-mediated place aversion: MP1104, a dual κOR-δOR agonist is an analgesic and anti-addiction agent with attenuated side effects
Susruta Majumdar

67 - Dissecting dopamine pathways altered by pain-induced dysfunction in opioid signaling
Tamara Markovic

68 - Pain Recruits Accumbal Kappa Opioid System And Alters Opioid Consumption.
Nicolas Massaly

69 - Design and Synthesis of Collybolide Probes for Kappa-Opioid Receptor
Nicholas P. Massaro

70 - Trafficking and Signaling of Endogenous Mu-Delta Heteromers
Dominique Massotte

71 - Measurement of Heroin Antibody Binding Affinity Using Microscale Thermophoresis
Gary Matyas

72 - Neuroinflammatory effects of HIV-1 Tat protein correlate with elevated brain dopamine levels and increased morphine consumption and conditioned place preference (CPP), and are prevented by indomethacin treatment
Jay McLaughlin

73 - AGONIST FUNCTIONAL SELECTIVITY DETERMINED BY RGS PROTEINS
Kylie B. McPherson

74 - Single-particle tracking as an effector-independent readout of mu opioid receptor activity after agonist exposure
Marissa Metz

75 - The delta opioid receptor as an emerging therapy for mTBI-induced headaches
Laura Moye

76 - Identifying the role of peripheral delta opioid receptors in chronic migraine
Laura Moye

77 - Ethanol disrupts synaptic specific mu opioid receptor-mediated long term depression in dorsal striatum
Braulio Munoz

78 - Free fatty acid receptor hypothalamic GPR40/FFAR1 regulate β-endorphin release via prohormone convertase 2 protein expression
Kazuo Nakamoto

79 - Opiate Use Disorder in Pregnancy in Crawford County, Ohio: A Case Study
Madeline L. Novack

80 - The effects of commonly used opioids in cell cultures
Erik Nylander

81 - Metformin acting through the mammalian target of rapamycin complex 1 (mTORC1) attenuates morphine efficacy in a mouse model of neuropathic pain.
Ilona Obara

82 - Development of a Selective Antagonist for the Mu-Delta Heterodimer
Keith M. Olson

83 - Nociceptin receptor trafficking in midbrain dopamine neurons
Patrick R O'Neill

84 - Spinal pain regulation of the N/OFQ-NOP receptor system in a spinal nerve injury mouse model
Akihiko Ozawa

85 - A novel non-canonical role of RGS4 in δ-opioid receptor mediated neuronal outgrowth and differentiation
Paschalina Pallaki

86 - Genetic dissociation of morphine analgesia from hyperalgesia in mice
Gavril Pasternak

87 - Analgesic and Anti-Inflammatory Effects of Novel Kappa Opioid Receptor Agonist 16-Ethynyl Salvinorin A
Kelly Paton

88 - Morphine-dosing affects development of antinociceptive tolerance
Alok Kumar Paul

89 - Role of mu opioid receptor A112G SNP in the mesolimbic neurocircuitry
Dina Popova

90 - Imatinib prevents morphine tolerance without inducing MOR endocytosis.
Puig S.

91 - Serotonergic and adrenergic gene variants and vulnerability to non-dependent opioid use and heroin dependence in a Dutch population
Matthew Randesi

92 - Conditioned place aversion to an “extremely” G-protein biased kappa opioid receptor agonist in C57BL6 mice
Brian Reed

93 - Critical role of Gi-protein signaling in the dorsal striatum for the reduction of voluntary alcohol consumption in C57Bl/6 mice
Meridith Robins

94 - Convergent and Divergent Behavioral Changes Caused by Different Patterns of Morphine Exposure in Mice
Patrick E. Rothwell

95 - Anxiolytic-like and antidepressant-like effects of a novel delta opioid receptor agonist NC-2800 in rats
Akiyoshi Saitoh

96 - Ligand-receptor and structure-function relationship studies on differently substituted diphenethylamines interacting with the κ-opioid receptor
Helmut Schmidhammer

97 - Carboxyl-terminal multisite phosphorylation regulates µ-opioid receptor desensitization and tolerance
Stefan Schulz

98 - Beyond cAMP assays: GIRK channels as ultra-sensitive sensors for the characterization of novel opioids using the voltage-sensitive dye FMP
Stefan Schulz

99 - COLLYBOLIDE, A NOVEL BIASED AGONIST TO STUDY KAPPA-OPIOID RECEPTOR PHARMACOLOGY
Indrajeet Sharma

100 - Opioid-Elicited Erk1/2 Phosphorylation, Elk-1 and CREB Activation, and Lipid Raft Localization in HEK 293 Cells Coexpressing μ-Opioid and Nociceptin Receptors
Cynthia Wei-Sheng Lee

101 - Effect of Magnetic Acupuncture Attachment on Neigun(acupoint P6) on Autonomic Nervous System
Hyun Hwa Shin

102 - TRV0109101, a G protein-biased agonist of the µ-opioid receptor, does not promote opioid-induced mechanical allodynia following chronic administration
Edward R. Siuda

103 - Dissecting Mechanisms of Nociceptin Opioid Peptide Receptor Regulation
Skylar Spangler

104 - Injectable peptide-based hydrogels as efficient matrices for the controlled-delivery of opioid analgesics
Mariana Spetea

105 - Studies with Nociceptin/Orphanin FQ Peptide (NOP) Receptor knockout rats reveal NOP receptor-dependent sex differences in nociceptive sensitivity, anxiety-like behaviors and serum N/OFQ and CORT levels in response to traumatic stress
Kelly M. Standifer

106 - A pH-sensitive opioid analgesic designed by modeling of pathological receptor-ligand interactions
Christoph Stein

107 - Hsp90 and PEBP Promote Opioid Anti-Nociception Through the Regulation of Mu Receptor Signal Transduction Cascades
John M. Streicher

108 - Modulation of endogenous opioid-mediated antinociception by regulator of G protein signaling (RGS) proteins
Sherrica Tai

109 - Label-free mass spectrometry based quantitation of peptides related to chronic migraine and opioid-induced hyperalgesia (OIH) in mice
Krishna D. B. Anapindi

110 - Overlapping mechanisms between opioid induced hyperalgesia and chronic migraine
Alycia Tipton

111 - Influence of tramadol in global cerebral ischemia-induced mechanical allodynia
Shogo Tokuyama

112 - In Vitro And In Vivo Profile Of PPL-101 And PPL-103: Mixed Opioid Partial Agonist Analgesics With Low Abuse Potential
Lawrence Toll

113 - Effects of Heroin on Prosocial Behavior in Rats
Seven Tomek

114 - Characterization of the endogenous small-sized peptides released in the nucleus accumbens related to pain modulation
Moe Watanabe

115 - Automated detection of Mu Opiod Receptor recycling reveals distinct subpopulations of exocytic events
Zara Weinberg

116 - Development of a Virtual Reality Paradigm for in vivo Hippocampal Imaging During Morphine Conditioned Place Preference
Sidney Williams

117 - Activation, Desensitization and Trafficking of total phosphodeficient MORs in the MOR-knockout rat
John T Williams

118 - Inflammatory Pain Changes The Expression and Function Of CB1 Receptors in The Periaqueductal Gray
Adrianne R. Wilson-Poe

119 - Naltrexone and Nalmefene Attenuate Cocaine Place Preference but Differentially Effect Cocaine Locomotor Sensitization
KA Windisch

120 - A Novel assay for measuring human μ-opioid receptor’s functional activity
Jinhua Wu

121 - POTENTIAL OF CIRCULATING MU-OPIOID RECEPTOR AND TOLL-LIKE RECEPTOR-4 ACTIVATION IN MORPHINE-ADMINISTERED MICE
Nan XIE

122 - Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine
Jin Xu

123 - Design and synthesis a novel κ opioid receptor agonists isolating both sedation and aversion.
Masahiro Yata

124 - The effects of chronic stress on alcohol consumption in μ-opioid receptor knockout mice
Moriya Yuki

125 - Commonly used opioids induce neurotoxic effects in neuronal cell cultures
Sofia Zelleroth

Registration period:

Submission period: